Clinical Trial 64243

Tucson, AZ 85704


Summary:

Major Depressive Disorder (MDD), also known as clinical depression, is a common and serious mental health condition characterized by persistent feelings of sadness, hopelessness, and a lack of interest or pleasure in daily activities. It can affect how a person thinks, feels, and functions, both emotionally and physically. Symptoms may include fatigue, changes in sleep and appetite, difficulty concentrating, and thoughts of self-harm or suicide. MDD is treatable, often through a combination of psychotherapy, medication, and lifestyle changes. Early diagnosis and support can significantly improve outcomes.

We are seeking volunteers for a clinical study evaluating the safety and effectiveness of a treatment for Major Depressive Disorder (MDD).
If you or someone you know may be interested, please contact us to learn more about eligibility and potential benefits.


Qualified Participants Must:

• Must be 18 years old and above
• Diagnose or Suffering from Major Depressive Disorder (MDD)


Qualified Participants May Receive:

  • Compensation: Get compensated up to $100 per clinic visit with no cost to you or your insurance!
  • Comprehensive Support: Regular check-ins and assessments to ensure your health is a priority. Our trial is conducted by experienced healthcare professionals dedicated to your well-being.
  • Free study medications: Study medications for Hidradenitis Suppurativa (HS) are given at no cost.


Available At:

Noble Clinical Research
2055 W Hospital Drive Suite 145
Tucson, AZ 85704
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.